METP PHARMA
For some indications and drugs, the nasal application is superior to other application methods. This is mainly due to the fact that nasal mucosa and olfactory epithelium are providing a unique connection for allowing substances to enter peripheral circulation and central nervous system (CNS).
METP PHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Address:
Emmetten, Nidwalden, Switzerland
Country:
Switzerland
Website Url:
http://www.mattern-pharma.com
Status:
Active
Contact:
+41-41-618 30 30
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Euro TYPO3
Similar Organizations
Current Employees Featured
Official Site Inspections
http://www.mattern-pharma.com
- Host name: mail.pixelpusher.ch
- IP address: 80.74.158.48
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "MetP Pharma"
Nasal drug delivery — MetP Pharma AG
Dec 9, 2019 · MetP Pharma AG is a private company and based near Lucerne, Switzerland, held by us, Claudia Mattern, PhD, CSO, and Udo Mattern, CEO. «What is your molecule? Have it …See details»
It startet with Rhinomer — MetP Pharma AG - Mattern …
We have been developing nasal applications since the mid 1990s. For example, we are proud to have invented the first nasal OTC multi-dose container functioning without any preservatives, being a big sensation at the time. We …See details»
Strategic partnership — MetP Pharma AG - Mattern …
We seek to establish strategic partnerships with pharmaceutical companies. Our part consists in carrying out the pharmaceutical development in consultation with the partner and licensing our technology, e.g. by compound, indication, area …See details»
MetP Pharma AG: New Nasal Gel Evaluated for its Protective
Aug 24, 2020 · MetP (R) Pharma AG is an independent, specialized pharmaceutical R&D company based in Switzerland. The company has developed an advanced and …See details»
Secarna Pharmaceuticals and MetP Pharma enter into a co
Nov 16, 2018 · MetP Pharma AG, founded by Udo and Claudia Mattern, is a privately held company, focusing on the nasal delivery of drugs to the systemic circulation and brain.See details»
MetP Pharma - Craft
MetP Pharma is a company that develops a nasal drug delivery platform. It is designed to promote the administration of systemic-acting drugs with low oral bioavailability and drugs that are …See details»
MetP Pharma AG – Swiss Biotech
To support its members, the association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources.See details»
Glucagon-like peptide-1 (GLP-1) Receptor Agonist Semaglutide
May 8, 2024 · Dr Claudia Mattern, chief scientific officer at MetP Pharma, says: “The preclinical studies clearly show that the oleogel formulation with BrainDos increases the delivery of …See details»
Benefits of nasal application — MetP Pharma AG
Our own nasally applied pipeline products meet innovative indications and provide an improved pharmacokinetic and pharmacodynamic profile. Until now, your agent is applied by transdermal patch, by oral intake or even rectally, …See details»
MetP Pharma - Products, Competitors, Financials, Employees ...
Oct 9, 2024 · MetP® Pharma AG is an independent, specialized pharmaceutical R&D and product development company based in Switzerland. The company has developed BrainDosâ„¢, an …See details»
MetP Pharma AG: New Nasal Gel Evaluated for its Protective …
Aug 24, 2020 · MetP (R) Pharma AG is an independent, specialized pharmaceutical R&D company based in Switzerland. The company has developed an advanced and …See details»
MetP® Pharma Introduces Nascum®-Plus Against the Onset of
Oct 5, 2018 · MetP® Pharma AG is an independent, specialized pharmaceutical R&D company based in Switzerland. The company has developed an advanced and comprehensively …See details»
Dopamine intranasal - Mattern Pharmaceuticals - AdisInsight
If your organization or you do not have a subscription, try one of the following: Contacting your organization’s admin about adding this content to your AdisInsight subscription Buying a PDF …See details»
Mono-dose device Lecticula — MetP Pharma AG - Mattern Pharma
Our patented mono-dose device is an integral part of MetP’s platform for effective nasal application of semi-solid dosage forms – next to our semi-solid carrier gel matrix and the …See details»
MetP Pharma Receives US Patent for Drug Therapy of ... - BioSpace
Dec 9, 2019 · MetP® Pharma AG is an independent, specialized pharmaceutical R&D company based in Switzerland. The company has developed an advanced and comprehensively …See details»
Pharma Tech Industries | VentureRadar
Pharma Tech Industries (PTI) is a family owned and operated pharmaceutical contract manufacturing organization offering fully-integrated supply chain support and highly …See details»
Andreas Mattern | Pharma Manufacturing
Vice President Strategy & Global Product Management Pharma, Syntegon Technology . Load More Content . https://www.facebook.com/pages/Pharmaceutical-Manufacturing ...See details»
Filling unit Maxima — MetP Pharma AG - mattern-pharma.com
At MetP Pharma AG, we are capable to produce up to 50 million mono-dose devices per year. Also, pilot samples containing your drug molecule can be produced quickly, for R&D or clinical …See details»
Pattern Pharma - Pattern Pharma
Pattern Pharma is a biopharmaceutical company with therapeutics that mobilize innate immunity to address the immune failures underpinning many diseases, with a particular focus on cancer.See details»
Gel carrier matrix Silcum — MetP Pharma AG - Mattern Pharma
To have the agent efficiently and reliably delivered, it needs to be integrated into some form of a carrier. MetP has developed a gel matrix providing this function: a semi-solid oil-based …See details»